Physician profile
Lawrence E Donato
NPI 1497701189
$6,657.07
in general payments reported to CMS, 2019-2025
10 companies · $532 in 2025
The $532 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,372 · 2020: $73.32 · 2021: $182 · 2022: $1,649 · 2023: $392 · 2024: $457 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295 · Travel and Lodging: $85.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.17 |
| Travel and Lodging | $85.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,696.11 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, The Pink Hip Kit - Smith & Nephew Table |
| Fortis Surgical, LLC | $1,375.04 | 2022-2025 | |
| Stryker Corporation | $434.93 | 2022-2024 | Procinch, Cinchlock |
| Bioventus LLC | $276.70 | 2021-2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Depuy Synthes Sales INC. | $267.80 | 2019-2025 | Truespan Orthocord, N/A, Gryphon Orthocord |
| Miach Orthopaedics, INC. | $257.70 | 2023 | |
| Horizon Therapeutics Plc | $216.83 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $89.62 | 2019 | |
| Convatec INC. | $23.65 | 2024 | |
| Fidia Pharma USA INC. | $18.69 | 2023 | Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Donato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.